Home Newsfeeds INOVIO Says Phase 2 REVEAL2 Trial Evaluating VGX-3100 Did Not Meet Primary Endpoint

INOVIO Says Phase 2 REVEAL2 Trial Evaluating VGX-3100 Did Not Meet Primary Endpoint

Announces topline results from REVEAL2, the second Phase 3 trial evaluating VGX-3100 as a treatment for cervical high-grade squamous intraepithelial lesions (HSIL) Trial results did not meet the primary endpoint in

byBenzinga Newsdesk

March 1, 2023

1 minute read

Announces topline results from REVEAL2, the second Phase 3 trial evaluating VGX-3100 as a treatment for cervical high-grade squamous intraepithelial lesions (HSIL)
- Trial results did not meet the primary endpoint in the biomarker-selected population
  - Trial results did achieve statistical significance in the all-participants population

If You Invested $100 In This Stock 5 Years Ago, You Would Have $700 Today

By Benzinga Insights

February 14, 10:00 AM

Lattice Semiconductor (NASDAQ:LSCC) has outperformed the market over the past 5 years by 33.28% on an annualized basis…

LSCC

AMD To Announce Q4 Results On Tuesday Amid Challenging Times For Semiconductor Industry: What Investors Should Expect

By Shanthi Rexaline

January 31, 7:00 AM

Advanced Micro Devices Inc. (NASDAQ: AMD) is scheduled to report its fourth-quarter results on Tuesday after market close. An earnings conference call will follow at 5 p.m. EST.

AMD

ESSA Pharma Presents Updated Phase 1 Masofaniten Clinical Data At The 2024 ASCO Genitourinary Cancers Symposium

By Benzinga Newsdesk

January 25, 11:01 AM

Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPCPhase 2 dose expansion currently underway at the RP2CDs of masofaniten 600 mg BID

EPIX

Watching Roblox; Bear Cave Newsletter Issues Short Report On Co Titled “Problems At Roblox (RBLX)”

By Happy Mohamed

August 17, 10:32 AM

https://thebearcave.substack.com/p/even-more-problems-at-roblox-rblx Roblox (NYSE:RBLX, $18.0 billion)) is a popular platform for children generally between six and fourteen to play online. The Bear Cave

RBLX

INOVIO Says Phase 2 REVEAL2 Trial Evaluating VGX-3100 Did Not Meet Primary Endpoint

Related Posts

If You Invested $100 In This Stock 5 Years Ago, You Would Have $700 Today

AMD To Announce Q4 Results On Tuesday Amid Challenging Times For Semiconductor Industry: What Investors Should Expect

ESSA Pharma Presents Updated Phase 1 Masofaniten Clinical Data At The 2024 ASCO Genitourinary Cancers Symposium

Watching Roblox; Bear Cave Newsletter Issues Short Report On Co Titled “Problems At Roblox (RBLX)”